We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
-6.06%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$1.79B
AUM Growth
-$53.7M
Cap. Flow
+$77.8M
Cap. Flow %
4.35%
Top 10 Hldgs %
81.39%
Holding
42
New
12
Increased
7
Reduced
8
Closed
4

Top Buys

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$234M
2
ADBE icon
Adobe
ADBE
+$152M
3
PANW icon
Palo Alto Networks
PANW
+$61.9M
4
PCT icon
PureCycle Technologies
PCT
+$37.4M
5
U icon
Unity
U
+$23M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$189M
2
CRM icon
Salesforce
CRM
+$170M
3
MSFT icon
Microsoft
MSFT
+$130M
4
NCNA
NuCana
NCNA
+$3.84M
5
FSDC
FS Development Corp. Class A Common Stock
FSDC
+$2.75M

Sector Composition

Rank Sector Weight
1 Healthcare 44.96%
2 Technology 21.24%
3 Financials 12.87%
4 Communication Services 7.46%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PDD icon
26
Pinduoduo
PDD
$129B
$5.69M 0.32%
+42,490
New +$7.17M
IJR icon
27
iShares Core S&P Small-Cap ETF
IJR
$112B
$5.46M 0.31%
50,304
+594
+1% +$62.2K
NCNA
28
NuCana
NCNA
$5.58M
$4.95M 0.28%
198
-138
-41% -$3.84M
FULC icon
29
Fulcrum Therapeutics
FULC
$288M
$4.84M 0.27%
410,714
– –
IJH icon
30
iShares Core S&P Mid-Cap ETF
IJH
$125B
$4.2M 0.23%
80,645
-630
-0.8% -$31.5K
VWO icon
31
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$4.19M 0.23%
80,501
+141
+0.2% +$7.51K
PRDS
32
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$3.98M 0.22%
+400,000
New +$4.14M
DNTH icon
33
Dianthus Therapeutics
DNTH
$6.15B
$3.94M 0.22%
20,788
– –
DBTX
34
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$3.73M 0.21%
+328,798
New +$5.16M
IRON icon
35
Disc Medicine
IRON
$3.03B
$3.39M 0.19%
+8,333
New +$3.72M
MCRB icon
36
Seres Therapeutics
MCRB
$48.4M
$2.71M 0.15%
6,592
– –
DYN icon
37
Dyne Therapeutics
DYN
$4.89B
$1.67M 0.09%
107,252
– –
DADA
38
DELISTED
Dada Nexus
DADA
$1.35M 0.08%
+49,887
New +$1.9M
CG icon
39
Carlyle Group
CG
$17.9B
– –
-23,600
Closed -$742K
PGNY icon
40
Progyny
PGNY
$2.46B
– –
-3,755
Closed -$159K
TWLO icon
41
Twilio
TWLO
$29.3B
– –
-2,021
Closed -$684K
FSDC
42
DELISTED
FS Development Corp. Class A Common Stock
FSDC
– –
-250,000
Closed -$2.75M
1
2

Similar funds

DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

Harvard Management Company's Q1 2021 Portfolio in Review

As of Q1 2021, Harvard Management Company held 42 positions worth $1.79B, down 2.9% from $1.84B the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Harvard Management Company deployed $77.8M of net new capital in Q1 2021, opening 12 new positions and adding to 7 existing holdings. Its largest new stake was Intercontinental Exchange: 2,062,444 shares worth $230M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 58% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Royalty Pharma, an estimated $189M trimmed.

  • Harvard Management Company's largest Q1 2021 buy was Intercontinental Exchange: 2,062,444 shares worth $230M.
  • Harvard Management Company added most to Palo Alto Networks in Q1 2021, an estimated $61.9M increase.
  • Harvard Management Company's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $189M.
  • Harvard Management Company fully exited FS Development Corp. Class A Common Stock in Q1 2021, selling an estimated $2.75M.
  • Harvard Management Company's ten largest holdings make up 81% of its $1.79B portfolio in Q1 2021.
  • Harvard Management Company opened 12 new positions and closed 4 in Q1 2021.
  • Harvard Management Company's portfolio value fell 2.9% quarter-over-quarter to $1.79B.

Based on Harvard Management Company's 13F filing for Q1 2021, filed 7 May 2021.